SUBSCRIBE
SUBSCRIBE
News   Business

Biogen Idec, Inc. (Massachusetts) Reports Third Quarter 2005 Results

October 27, 2005 | 
1 min read
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct. 26, 2005--Biogen Idec Inc. (NASDAQ: BIIB), a global biotechnology leader with leading products and capabilities in oncology, neurology and immunology, today reported its third quarter 2005 results.
Earnings
Biogen
MORE ON THIS TOPIC
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
AstraZeneca Finds Another Jewel in China With up to $2B For KRAS Inhibitor
December 22, 2025
 · 
1 min read
 · 
Annalee Armstrong
Digital overload and its impact on the human brain, showcasing fragmented thoughts, information overload. Abstract design art collage. Social media digital addiction, mental health, stress, anxiety
Business
BioSpace Editors’ Top 5 Biggest News Stories of the Year
December 22, 2025
 · 
10 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Voyager Loses 30 Employees After Novartis Prunes Deal
December 19, 2025
 · 
98 min read
 · 
BioSpace Editorial Staff
3D illustration Cloud with coins hanging for business and money saving concept, Minimal creative scene 3d render.
Rare diseases
Kyowa Kirin Could Get Windfall From Updated Newborn Screening Recommendations
December 19, 2025
 · 
2 min read
 · 
Dan Samorodnitsky